Davis R. Ingram
-
- Sarcoma Diagnosis and Treatment 36
- Rheumatology top 5%
- Oncology top 5%
- Vascular Tumors and Angiosarcomas 12
- Peptidase Inhibition and Analysis 4
- CAR-T cell therapy research 4
- Neurology top 5%
- Neurofibromatosis and Schwannoma Cases 9
- Oral Surgery top 5%
-
- Cardiac tumors and thrombi 9
-
- Protein Degradation and Inhibitors 7
-
- Cancer-related molecular mechanisms research 4
- Co-authors
- Alexander J. LazarWei‐Lien WangKeila E. TorresDina LevElizabeth G. DemiccoRaphael E. PollockNeeta SomaiahGhadah Al Sannaa
- Journals
- Journal of Clinical Oncology (2 papers)SHILAP Revista de lepidopterología (1 paper)Molecular Cell (1 paper)
- Partner nations
- United StatesCanadaNetherlands
In The Last Decade
Davis R. Ingram
54 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 89
- Pulmonary and Respiratory Medicine 947
- Rheumatology 343
- Oncology 559
- Neurology 282
- Oral Surgery 109
Countries citing papers authored by Davis R. Ingram
This map shows the geographic impact of Davis R. Ingram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davis R. Ingram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davis R. Ingram more than expected).
Fields of papers citing papers by Davis R. Ingram
This network shows the impact of papers produced by Davis R. Ingram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davis R. Ingram. The network helps show where Davis R. Ingram may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Davis R. Ingram, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 19 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 5 | |
| 10 | 2022 | 13 | |
| 11 | 2021 | 1 | |
| 12 | 2018 | 46 | |
| 13 | 2018 | 173 | |
| 14 | 2017 | 21 | |
| 15 | 2016 | 162 | |
| 16 | 2016 | 6 | |
| 17 | 2016 | 15 | |
| 18 | 2015 | 11 | |
| 19 | 2014 | 131 | |
| 20 | 2010 | 81 |
About Davis R. Ingram
Davis R. Ingram is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Neurology, having authored 59 papers that have together received 1.8k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (36 papers), Vascular Tumors and Angiosarcomas (12 papers), Cardiac tumors and thrombi (9 papers), Neurofibromatosis and Schwannoma Cases (9 papers), Protein Degradation and Inhibitors (7 papers), Peptidase Inhibition and Analysis (4 papers), Cancer-related molecular mechanisms research (4 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (947 citations), Rheumatology (343 citations) and Oncology (559 citations). Davis R. Ingram has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Alexander J. Lazar, Wei‐Lien Wang, Keila E. Torres, Dina Lev, Elizabeth G. Demicco, Raphael E. Pollock, Neeta Somaiah, Ghadah Al Sannaa, Kelsey L. Watson and Jason L. Hornick. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.